Condition: Hepatocellular Carcinoma Non-resectable · Sponsor: RWTH Aachen University
The study investigates the adjuvant SBRT following TACE in early and intermediate stages HCC not amenable for surgical resection.
This description comes directly from the study's public registry record.
Ahmed Allam Mohamed, MBBS,MSc, MD · +49241 80-8926 · amohamed@ukaachen.de
Always discuss trial participation with your own doctor first.
| RWTH Aachen University Hospital | Aachen, North Rhine-Westphalia, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04996914